Details

Autor(en) / Beteiligte

• Widmark, A
• Gunnlaugsson, A
• Beckman, L
• Thellenberg-Karlsson, C
• Hoyer, M
• Lagerlund, M
• Fransson, P
• Kindblom, J
• Ginman, C
• Johansson, B
• Seke, M
• Björnlinger, K
• Kjellén, E
• Franzen, L
• Nilsson, P

Titel

Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial “HYPO-RT-PC”

Ist Teil von

• International Journal of Radiation Oncology, Biology, Physics, 96 (5), s. 938–939, 2016, Vol.96 (5), p.938-939

Ort / Verlag

Elsevier Inc

Erscheinungsjahr

2016

Quelle

Elsevier ScienceDirect Journals Complete

Beschreibungen/Notizen

• Prostate cancer is postulated to have high radiation-fractionation sensitivity, which suggests a potential therapeutic benefit for hypofractionated (HF) radiotherapy (RT). Results from randomized studies investigating efficacy and side effects of moderately hypofractionated (M-HF) schedules have recently been reported in the literature. Data from randomized trials with extreme hypofractionation (E-HF) are however hitherto lacking. We here report two-year toxicity results from the Scandinavian multicenter phase III trial (HYPO-RT-PC) comparing E-HF with conventional fractionation (CF).